Gossamer Bio (GOSS) Current Assets (2018 - 2026)

Gossamer Bio has reported Current Assets for 9 years, with the latest figure at $72.7 million in Q2 2026.

• On a quarterly basis, Current Assets fell 69.17% year-over-year to $72.7 million in Q2 2026; TTM through Jun 2026 was $72.7 million, a 69.17% decrease from a year earlier, with the FY2025 full-year figure at $167.6 million, down 45.9% from the prior year.
• Current Assets was $72.7 million for Q2 2026 at Gossamer Bio, down from $124.5 million in the prior quarter.
• The five-year high for Current Assets was $370.9 million in Q2 2024, with the low at $72.7 million in Q2 2026.
• Average Current Assets over 5 years is $248.9 million, with a median of $258.6 million recorded in 2022.
• The sharpest annual moves came in 2024 and 2026: Current Assets jumped 113.93% in 2024, then tumbled 69.17% in 2026.
• Over 5 years, Current Assets stood at $261.9 million in 2022, then advanced by 17.05% to $306.5 million in 2023, then climbed by 1.1% to $309.9 million in 2024, then tumbled by 45.9% to $167.6 million in 2025, then plunged by 56.62% to $72.7 million in 2026.
• The last three Current Assets figures came in at $72.7 million (Q2 2026), $124.5 million (Q1 2026), and $167.6 million (Q4 2025), per Business Quant data.